Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
מצבים רפואיים
Glioblastoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Department of Radiation Oncology, University Hospital Augsburg, Augsburg, Germany
Contact: Study coordinator (Klaus-Henning Kahl, Dr.) · klaushenning.kahl@uk-augsburg.de · +49 821 400 168564Department of Radiation Oncology, University Hospital Köln, Cologne, Germany
Contact: Study coordinator (Emmanouil Fokas, Prof. Dr.) · emmanouil.fokas@uk-koeln.de · +49 221 478 84763Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany
Contact: Study coordinator (Markus Diefenhardt, Dr.) · markus.diefenhardt@unimedizin-ffm.de · +49 69 63 010Department of Radiation Oncology, University Hospital Freiburg, Freiburg im Breisgau, Germany
Contact: Study coordinator (Maren Paulmann, Dr.) · maren.paulmann@uniklinik-freiburg.de · +49 761 270 9463Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany
Contact: Study coordinator (Clemens Seidel, PD Dr.) · clemens.seidel@medizin.uni-leipzig.de · +49 341 971 8400Department of Radiation Oncology, Medical Faculty Mannheim, Mannheim, Germany
Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
Department of Neurology, University Hospital Regensburg, Regensburg, Germany
Contact: Study coordinator (Cecilia Vasquez Robinet) · cecilia.vasquez-robinet@ukr.de · +49 941 944 18743Department of Radiation Oncology, Tübingen, Germany
Contact: Study coordinator (Barbara Gehler, Dr.) · pride_tuebingen@med.uni-tuebingen.de · +49 7071 29 68463
מובילי המחקר
Maximilian Niyazi, Prof. Dr.
Principal Investigator
University Hospital Tuebingen, Department of Radiation Oncology